Literature DB >> 11911346

Gastric carcinoid tumors without autoimmune gastritis in Japan: a relationship with Helicobacter pylori infection.

Yuichi Sato1, Mitsuya Iwafuchi, Jun-Ichi Ueki, Akira Yoshimura, Tsutomu Mochizuki, Hirotaka Motoyama, Kazuhito Sugimura, Terasu Honma, Rintaro Narisawa, Takafumi Ichida, Hitoshi Asakura, D H Van Thiel.   

Abstract

In Japan, most cases of gastric carcinoid tumor (GCT) are unassociated with either autoimmune gastritis (AIG) showing type-A chronic atrophic gastritis (CAG-A) or Zollinger-Ellison syndrome (ZES). However, the pathogenesis of this tumor remains unknown. Recent studies have determined that Helicobacter pylori infection induces gastric carcinoid in Mongolian gerbils and that H. pylori lipopolysaccharide exerts a mitogenic effect on ECL cells. We examined five patients with histologically diagnosed GCT, 40 patients with H. pylori-positive gastric ulcer (Hp+GU), 24 patients with H. pylori-positive duodenal ulcer (Hp+DU), and 12 patients with AIG showing CAG-A topographically. We compared the prevalence of H. pylori infection, and the levels of gastrin and pepsinogen (PG) in the serum of patients with GCT with those of patients with Hp+GU, or Hp+DU, and AIG. We also investigated the histological characteristics of the tumor and the gastric corpus mucosa in the GCT patients. The levels of serum gastrin and PG I and II were measured using an RIA kit. In all five (100%) patients with GCT, H. pylori infection was present, without any evidence of AIG or ZES. The serum levels of gastrin in the GCT patients were higher than those in either Hp+GU or Hp+DU patients and lower than those in the AIG patients. In contrast, serum PG I levels and the PG I/II ratio were lower in the GCT group than in the Hp+GU or Hp+DU groups. Histologically, all GCTs were ECL cell tumors and peritumoral corporal mucosal atrophy was observed in four of the five patients with GCT. In conclusions, H. pylori infection and hypergastrinemia were found in the patients with GCT without AIG. This finding suggests that H. pylori infection may induce corporal mucosal atrophy and hypergastrinemia that can produce a GCT with time.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11911346     DOI: 10.1023/a:1017972204219

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  43 in total

1.  Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia.

Authors:  R Eissele; G Brunner; B Simon; E Solcia; R Arnold
Journal:  Gastroenterology       Date:  1997-03       Impact factor: 22.682

2.  Effect of eradication of Helicobacter pylori in patients with fundic atrophic gastritis.

Authors:  A Tucci; G Biasco; G F Paparo
Journal:  N Engl J Med       Date:  1997-03-27       Impact factor: 91.245

3.  Influence of age and Helicobacter pylori infection on serum pepsinogens in healthy blood transfusion donors.

Authors:  R A Veenendaal; I Biemond; A S Peña; W van Duijn; J Kreuning; C B Lamers
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

4.  Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats.

Authors:  H Larsson; E Carlsson; H Mattsson; L Lundell; F Sundler; G Sundell; B Wallmark; T Watanabe; R Håkanson
Journal:  Gastroenterology       Date:  1986-02       Impact factor: 22.682

5.  Chronic gastritis in Japanese with reference to high incidence of gastric carcinoma.

Authors:  T Imai; T Kubo; H Watanabe
Journal:  J Natl Cancer Inst       Date:  1971-07       Impact factor: 13.506

6.  Antigastric autoantibodies in Helicobacter pylori infection: implications of histological and clinical parameters of gastritis.

Authors:  G Faller; H Steininger; J Kränzlein; H Maul; T Kerkau; J Hensen; E G Hahn; T Kirchner
Journal:  Gut       Date:  1997-11       Impact factor: 23.059

Review 7.  Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion.

Authors:  C J Gilligan; G P Lawton; L H Tang; A B West; I M Modlin
Journal:  Am J Gastroenterol       Date:  1995-03       Impact factor: 10.864

8.  Serum pepsinogen I and the state of gastric mucosa in an Estonian population sample.

Authors:  A Tamm; K Villako; M Härkönen; S L Karonen
Journal:  Scand J Gastroenterol       Date:  1984-11       Impact factor: 2.423

9.  Helicobacter pylori infection is the major risk factor for atrophic gastritis.

Authors:  H Kawaguchi; K Haruma; K Komoto; M Yoshihara; K Sumii; G Kajiyama
Journal:  Am J Gastroenterol       Date:  1996-05       Impact factor: 10.864

10.  Helicobacter pylori gastritis and serum pepsinogen levels in a healthy population: development of a biomarker strategy for gastric atrophy in high risk groups.

Authors:  T Knight; J Wyatt; A Wilson; S Greaves; D Newell; K Hengels; M Corlett; P Webb; D Forman; J Elder
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

View more
  15 in total

Review 1.  Endoscopic diagnosis and management of type I neuroendocrine tumors.

Authors:  Yuichi Sato
Journal:  World J Gastrointest Endosc       Date:  2015-04-16

Review 2.  Clinical features and management of type I gastric carcinoids.

Authors:  Yuichi Sato
Journal:  Clin J Gastroenterol       Date:  2014-09-17

3.  PELA microspheres loaded H. pylori lysates and their mucosal immune response.

Authors:  Jian-Min Ren; Quan-Ming Zou; Fu-Kun Wang; Qiang He; Wei Chen; Wen-Kun Zen
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

4.  Dynamic expression of pepsinogen C in gastric cancer, precancerous lesions and Helicobacter pylori associated gastric diseases.

Authors:  Pei-Fang Ning; Hui-Jie Liu; Yuan Yuan
Journal:  World J Gastroenterol       Date:  2005-05-07       Impact factor: 5.742

5.  Gastric carcinoid in a patient infected with Helicobacter pylori: a new entity?

Authors:  Pantelis Antonodimitrakis; Apostolos Tsolakis; Staffan Welin; Gordana Kozlovacki; Kjell Oberg; Dan Granberg
Journal:  World J Gastroenterol       Date:  2011-07-07       Impact factor: 5.742

Review 6.  Management of gastric and duodenal neuroendocrine tumors.

Authors:  Yuichi Sato; Satoru Hashimoto; Ken-Ichi Mizuno; Manabu Takeuchi; Shuji Terai
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

Review 7.  Gastrin May Mediate the Carcinogenic Effect of Helicobacter pylori Infection of the Stomach.

Authors:  Helge L Waldum; Øyvind Hauso; Øystein F Sørdal; Reidar Fossmark
Journal:  Dig Dis Sci       Date:  2014-12-06       Impact factor: 3.199

8.  Regression of type II gastric carcinoids in multiple endocrine neoplasia type 1 patients with Zollinger-Ellison syndrome after surgical excision of all gastrinomas.

Authors:  Melanie L Richards; Paul Gauger; Norman W Thompson; Thomas J Giordano
Journal:  World J Surg       Date:  2004-06-16       Impact factor: 3.352

9.  Multiple gastric carcinoids associated with parietal cell hyperplasia: intraoperative detection with a radiolabeled somatostatin analog.

Authors:  Yoshinori Hosoya; Kiichi Satoh; Mitsugu Hironaka; Mitsuhiro Nokubi; Kentaro Kurashina; Chiaki Shibayama; Hideharu Sugimoto; Kentaro Sugano; Hideo Nagai; Yoshikazu Yasuda
Journal:  Gastric Cancer       Date:  2008-07-02       Impact factor: 7.370

Review 10.  Gastritis, Gastric Polyps and Gastric Cancer.

Authors:  Helge Waldum; Reidar Fossmark
Journal:  Int J Mol Sci       Date:  2021-06-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.